Fairvalue-Calculator Fairvalue-Calculator
EN DE

Neuronetics, Inc (STIM) Fair Value & Analysis

Healthcare · US · Market cap $83.5M

Price$1.22
Fair Value$1.45
Upside+18.9%
Quality91/100
Evidence: Low Range $1.09 – $1.81

Fair value as of: Jun 24, 2026

Analysis

Neuronetics, Inc (STIM) currently trades at $1.22, while our model-based Fair Value estimate is $1.45 — implying the stock looks roughly 18.9% undervalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -9% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -5% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Neuronetics, Inc (STIM) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $1.45 versus a price of $1.22 — about +19% (undervalued). Model-based estimate, not financial advice.
What is the fair value of STIM?
Our 21-model fair value for Neuronetics, Inc is $1.45 (as of Jun 24, 2026), built from audited fundamentals. The current price is $1.22.
What is the quality score of STIM?
Neuronetics, Inc has a Quality Score of 91/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.